Product Information
CEFEPIME HCL 2 GRAM VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $5.3480 per EA under NDC 63323034020. Its NADAC has been published 122 times since Jan 22, 2014.
FDA first approved this application on Mar 20, 2008. Its Orange Book therapeutic-equivalence code is AP.
Strength
2 g/1
Manufacturer
Fresenius Kabi USA, LLCNDC
63323034020
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Effective Date
3/19/2025
Active Ingredients
CEFEPIME HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA065441FDA Approved
3/20/2008
TE Code
AP
On Market Since
8/30/2010
Pharmacological Classes
Price Statistics
The NADAC for CEFEPIME HCL 2 GRAM VIAL has been published 122 times since Jan 22, 2014, and over the history we have for it it has declined 32.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.3480 per EA |
|---|---|
| All-time high | $7.9605 (Dec 16, 2015) |
| All-time low | $5.3480 (Mar 19, 2025) |
| Median price | $7.9065 |
| Average price | $7.4932 |
| Largest weekly change | -30.1% (Nov 20, 2024) |
| Weeks tracked | 122 |
| Tracking since | Jan 22, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-32.8%
5Y
-32.8%
All
-32.4%
Last surveyed Apr 16, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFEPIME HCL 2 GRAM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFEPIME HCL 2 GRAM VIAL, manufactured by Fresenius Kabi USA, LLC, is $5.3480 per EA (NDC 63323034020), effective Apr 16, 2025.
How has the price of CEFEPIME HCL 2 GRAM VIAL changed over time?
Over the history we have for it, the NADAC for CEFEPIME HCL 2 GRAM VIAL has declined 32.4%. It has been tracked across 122 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for CEFEPIME HCL 2 GRAM VIAL?
Since Jan 22, 2014, the NADAC for CEFEPIME HCL 2 GRAM VIAL has ranged from a low of $5.3480 (Mar 19, 2025) to a high of $7.9605 (Dec 16, 2015), with a median of $7.9065 per EA.
Are there cheaper alternatives to CEFEPIME HCL 2 GRAM VIAL?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFEPIME HCL 2 GRAM VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures CEFEPIME HCL 2 GRAM VIAL?
CEFEPIME HCL 2 GRAM VIAL (NDC 63323034020) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.